Key points are not available for this paper at this time.
Chronic kidney disease is a global public health problem, involving about 10% of the global population.1 The awareness of this major burden is relatively recent and still incomplete. Unfortunately, the multifaceted burden of chronic kidney disease (prevalence, morbidity, mortality, costs) is relentlessly growing, particularly in low-income countries (LIC).1
Jadoul et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: